Listen to the discussion from the BIA’s Networking Breakfast on 20 April where we explored the need for more long-term, patient capital for the UK biotech sector with a panel of experts.

  • Steve Bates, CEO, BioIndustry Association (Chair)
  • Dr Matthew Wicks, Patient Capital Review, HM Treasury
  • Dr Abby Taylor, Development Programme Manager, Wellcome Trust
  • Dr Fiona Marshall, Chief Scientific Officer and Co-founder, Heptares Therapeutics, Industry Advisory Panel for the Patient Capital Review
  • Nikhil Rathi, Chief Executive Officer, London Stock Exchange and Director of International Development
  • Nick Johnston, Partner, Advisory, Perella Weinberg Partners